gene therapy

Beacon shines a light on positive early data from eye disease ph. 2

The company's gene therapy made for improvements in visual function for patients with X-linked retinitis pigmentosa at six months in its phase 2 study.

Zoey Becker May 7, 2025 7:15am

J&J gene therapy fails ph. 3 rare eye disease trial

May 5, 2025 11:33am

Vertex discontinues AAV research for gene therapies

May 2, 2025 6:22pm

Lexeo locks in pivotal trial plan as gene therapy data accrue

Apr 7, 2025 9:37am

Gene therapy biotech secures $150M for eye disease candidates

Apr 2, 2025 7:30am

Beam gene therapy passes early safety test in AATD

Mar 10, 2025 12:22pm